Lee Asplund’s Post

The side effects of cancer treatment are often cited as the more harrowing part of fighting the disease. But thanks to the success of a clinical trial at MUSC Hollings Cancer Center, and a $3.2 million grant from the National Cancer Institute, treatment for certain cancers may come with fewer complications. Brian Hess, M.D., and Shikhar Mehrotra, Ph.D., have partnered on a project to develop “purified” CAR-T cells to treat people with certain B-cell non-Hodgkin lymphomas who have already tried other therapies. CAR-T cell therapy is FDA-approved for certain types of blood cancer, but the Hollings trial is testing a new patented variation that the researchers hope will have longer-lasting results with fewer side effects. #ChangingWhatsPossible Read more: https://lnkd.in/ewBjKec8 #CancerResearch #cancer

Today is World Lung Cancer Day. This is an annual observance designed to commemorate those who are impacted by lung cancer and raise awareness about lung cancer. Listen to Claire's story which highlights how screening led to early detection and successful treatment of her lung cancer at Regional Hospital of Scranton. Lung screening has the potential to detect lung cancer at earlier stages when it has the best chance of being treated. Commonwealth Health Imaging screens high-risk patients for lung cancer at multiple locations using low-dose CT- https://lnkd.in/dxGMEF-Q

February 4th is World Cancer Day. Every year, around 45,000 people in Austria and 42,750 people in Switzerland receive a cancer diagnosis. Did you know, that the most common types of cancer are prostate cancer and breast cancer? This underlines the importance of personalized treatment choices, as different types of cancer have varying risk factors, detection rates and treatment options. Since the 1950s, our ongoing research has delved into pioneering cancer treatments, revolutionizing therapies through immuno-oncology. Today, we want to raise awareness for what matters most to us every day: the quality of life for those battling this disease!  #BMSAustria #BMSSwitzerland #WorldCancerDay   Sources: Statistik Austria, Press Release 25th of January 2024 Swiss Cancer Report 2021 by Federal Statistical Office, National Cancer Registration Center and Childhood Cancer Registry

In recognition of World Breast Cancer Research Day, we’re shining a light on breast cancer research and advocating for ongoing clinical trials to help the one in eight women who will be diagnosed with breast cancer in their lifetime and improve the way we treat cancer for the future.     Recent data is showing a shift in breast cancer diagnosis and treatment delivery with an increase in metastatic cases, which could be a result of COVID restrictions and increase in late diagnosis. We’re proud to operate a strong and growing clinical trials program across all modalities of treatment and cancer types, with 10% of our active trials focussed on breast cancer. With growing cancer rates, we continue our commitment to research and clinical trials and increasing access to new and emerging treatments to reduce the global cancer burden. Learn more about our research: https://lnkd.in/gD_NmUSX   #breastcancer #cancerresearch #breastcancerresearchday #clinicaltrials #research 

Today, on Stand Up To Cancer Research Day, we’re reminded of the power of early detection. Oral cancer screenings are a vital tool in the fight against cancer, helping identify potential issues before they become life-threatening. By catching oral cancer early, we increase the chances of successful treatment and a healthier future. Join us in standing up to cancer by scheduling your screening today and supporting the ongoing research that saves lives! Stand Up To Cancer was created to accelerate groundbreaking cancer research that will get promising new cancer treatments to patients quickly. We won’t stop until every cancer patient is a long-term cancer survivor.#StandUpToCancer #OralHealthcare #OralCancerScreening #SU2C #WeKeepPeopleSmiling

Today, the American Cancer Society released our 2024 Cancer Facts and Figures report. The data reveal that over 2 million NEW cancer cases are expected to be diagnosed in the U.S. These findings underscore the importance of cancer prevention and illuminate priority areas to address cancers whose incidence and/or mortality rates are inexplicably rising. Furthermore, the report highlights the critical need to invest in equitable application of proven cancer control interventions, and in discovery for new therapies -- especially for advanced-stage cancers. Both endeavors will be essential to accelerate progress against the 200 diseases we call cancer, and to save lives. https://lnkd.in/erhxiXwc

NEWS: 'Lung cancer is the deadliest of all cancers, and screening could save many lives − if more people could access it' Informative piece in The Conversation US by pulmonologist Nina Thomas who specializes in screening and diagnosing lung cancer. 'Between 2015 and 2019, survival rates for lung cancer have improved by 22%, in part because of an increase in earlier diagnosis. Most patients with early-stage lung cancer, however, have no symptoms and aren’t diagnosed until they reach more advanced stages that are harder to treat, underlining the need for effective lung cancer screening.' Read the full article here: https://lnkd.in/e6icFEn4 #screening #lungcancerscreening #LungCancerEurope #LuCE #LCSM #cancerscreening

The COVID-19 pandemic led to a significant drop in cancer cases in 2020 because of interruptions in screening and diagnostic services. A recent study looked at data from 22 cancer registries and found that while some cancers, like pancreatic cancer, almost returned to pre-pandemic levels in 2021, others, like thyroid cancer, had mixed recovery rates depending on the stage.  Metastatic breast cancer showed significantly higher observed rates than expected.   These results highlight the ongoing impact of the pandemic on healthcare services and show the need for continuous monitoring and adjustments in cancer care. Making sure we have strong screening and diagnostic services is critical to address the long-term effects on cancer outcomes. Link to the full article in the comments below. 📉 #bcsm #breastcancerawareness #cancer

Breast Cancer Awareness Month occurs every October, with the goal of raising awareness about the profound impact breast cancer has on thousands of Australians every day - breast cancer is the second most commonly diagnosed cancer in Australia. Aligned with this, at Omico, we are conducting an initiative called PrOSPeCT which includes providing comprehensive genomic profiling, at no cost, for people with advanced, incurable or poor prognosis cancers in Australia. If you are a patient living with breast cancer in Australia, you could be eligible for this initiative. To hear from real patients on their experience with comprehensive genomic profiling in their journey with cancer: https://lnkd.in/g8XM4XRd #BreastCancerAwarenessMonth #Togethercancermeetsitsmatch #Omico #CGP #ComprehensiveGenomicProfiling 

According to the American Cancer Society, Lung Cancer is the Leading Cause of Cancer Death in the United States. 🫁 About 80% of lung cancer deaths are thought to result from smoking 🫁 Lung cancer accounts for about 1 in 5 of all cancer deaths 🫁 Screening with low-dose CT can help detect lung cancer at its earliest stage, resulting in better outcomes Low-Dose CT is a quick and painless screening tool that uses low doses of radiation, comparable to a mammogram, to make detailed images of your lungs. These images are used to detect lung cancer at its earliest stages. https://lnkd.in/gPrjhzCd #HMI #LDCT #HoustonHealth